Publications by authors named "Caroline Besley"

Claim this Profile
P
Patient and Caregiver Experiences of CAR T Cell Therapy for Blood Cancer in the UK: A Qualitative Study.
Christel McMullan, Melanie J Calvert, Sarah E Hughes, Lester Pyatt, Bernie Kern, Caroline Besley

Patient· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older matched sibling donor vs young haploidentical donor for older patients with acute myeloid leukemia.
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Patrice Chevallier, Caroline Besley

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT.
Simona Pagliuca, Florent Malard, Jarl E Mooyaart, Michael Daskalakis, Ludovic Gabellier, Caroline Besley

Blood Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT.
Nicole Santoro, Christoph Schmid, Moniek de Witte, Mieke W H Roeven, Victoria Potter, Caroline Besley

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel.
Vaishali Dulobdas, Amy A Kirkwood, Fabio Serpenti, Brijesh Gautama, Aikaterini Panopoulou, Caroline Besley

Blood Cancer J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study.
Guillermo Ortí, Christophe Peczynski, William Boreland, Maeve O'Reilly, Malte von Bonin, Caroline Besley

Leukemia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT.
Piera Angelillo, Ana Alarcon Tomas, Edoardo Campodonico, Urban Novak, Ludovic Gabellier, Caroline Besley

Bone Marrow Transplant· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.
Anne Mea Spanjaart, Per Ljungman, Gloria Tridello, Juana Schwartz, Nuria Martinez-Cibrián, Caroline Besley

Leukemia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formed Visual Hallucinations Precipitated by Eyelid Closure After Stroke.
Caroline D Besley, Michael S Vaphiades, Lanning B Kline

J Neuroophthalmol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes.
Christianne Bourlon, Claire Roddie, Tobias Menne, Jane Norman, Maeve O'Reilly, Caroline Besley

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study.
Annalisa Ruggeri, Nicole Santoro, Jacques-Emmanuel Galimard, Krzysztof Kalwak, Mattia Algeri, Caroline Besley

Haematologica· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.
Maeve A O'Reilly, William Wilson, David Burns, Andrea Kuhnl, Frances Seymour, Caroline Besley

Hemasphere· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Gloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, Víctor Navarro, Tobias Menne, Caroline Besley

Hemasphere· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Macarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood, Denise Bonney, Kelly Watts, Caroline Besley

Blood Cancer J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics.
Kathleen P L Cheok, Amy A Kirkwood, Thomas Creasey, Eleni Tholouli, Sridhar Chaganti, Caroline Besley

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
Olaf Penack, Christophe Peczynski, Christian Koenecke, Emmanuelle Polge, Robin Sanderson, Caroline Besley

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma.
Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, Caroline Besley

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.
Olaf Penack, Christophe Peczynski, Christian Koenecke, Emmanuelle Polge, Andrea Kuhnl, Caroline Besley

J Immunother Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.
Per Ljungman, Gloria Tridello, Jose Luis Piñana, Fabio Ciceri, Henrik Sengeloev, Caroline Besley

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience.
Andrea Kuhnl, Claire Roddie, Amy A Kirkwood, Eleni Tholouli, Tobias Menne, Caroline Besley

Br J Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of CAR-T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories.
Ulrika Johansson, Kathleen Gallagher, Victoria Burgoyne, Marcela V Maus, Keagan S Casey, Caroline Besley

Cytometry B Clin Cytom· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD.
Jennifer A Ball, Andrew Clear, James Aries, Sarah Charrot, Caroline Besley

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use data.
Catherine S Y Lecat, Caroline Besley, Rachael E Hough, Asim Khwaja, Caroline Furness

Leuk Lymphoma· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.
Jeff K Davies, Sandra Hassan, Shah-Jalal Sarker, Caroline Besley, Heather Oakervee

Br J Haematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of phosphatidylinositol-3-kinase by the furanosesquiterpenoid hibiscone C.
Caroline Besley, Dena P Rhinehart, Taylor Ammons, Brian C Goess, Jason S Rawlings

Bioorg Med Chem Lett· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis